Toxikon Corp. has expanded its immunotoxicology offerings, adding flow cyctometry, which enables the direct analysis of cells to detect a variety of specifically labeled components.

Christopher Brynczka, Ph.D., head of immunotoxicology, clinical and histology services at Toxikon, said, “This is an opportunity for Toxikon to promote the development of our sponsor’s drugs and medical devices. If there are findings related to immune function in other preclinical studies, a more extensive evaluation of immunotoxicology is often necessary. The flow cytometer is so powerful that you can detect virtually any entity or event that occurs within a cell.”